Market open
$
198.67
Change
+4.68 +2.41%
Volume
Volume 1.77m
Dec 23, 2016, 12:39 p.m.
Real time quotes
Previous close
$ 193.99
$ 198.67
Change
+4.68 +2.41%
Day low
Day high
$193.74
$199.19
52 week low
52 week high
$184.50
$317.48
Market cap
$72.76B
Average volume
5.50M
P/E ratio
5.55
Rev. per Employee
$490,397
EPS
35.83
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on AGN
-
January is the cruelest month — for pharmacists
- Emma Court
-
Allergan's stock drops 1.3% after deal to buy Acelity unit for $2.9 bln in cash
- Tomi Kilgore
-
Small-cap fund produces big profits, even if some of its holdings don’t
- Philip van Doorn
-
Allergan's stock rose 0.1% after Forest subs settle federal probe
- Tomi Kilgore
-
Allergan's subs' settlement involves 3 Forest products sold from 2008 through 2011
- Tomi Kilgore
-
Allergan's Forest subsidiaries to pay $38 mln to settle federal probes into sales practices
- Tomi Kilgore
-
Analysts see these large-cap U.S. stocks rising at least 30% in 2017
- Philip van Doorn
-
Johnson & Johnson drops out of Actelion talks
- MarketWatch.com
-
Lonza nearing $5 bln deal for KKR's Capsugel
- MarketWatch.com
-
Novo Nordisk to limit price increases in the U.S.
- MarketWatch.com
-
Gundlach warns Trump trade is ‘losing steam’ and stocks have peaked
- Victor Reklaitis
-
Allergan shares climb 2.4% in premarket trade
- Ciara Linnane
-
Allergan announces settlement of patent litigation with Zydus Pharma and Cadila
- Ciara Linnane
-
Teva gets bump from Allergan deal, but sales dip
- MarketWatch.com
- Loading more headlines...
Where does this data come from?
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Sentiment on AGN
Analyst Ratings
Other News on AGN
-
Why Synergy Pharmaceuticals Is Jumping 10% Today
- Motley Fool
-
This Could Be The Perfect Time To Buy Allergan
- Seeking Alpha
-
Acelity Offloads Lifecell To Allergan For $2.9bn
- Seeking Alpha
-
Drastic Drug-Price Action No Trump Card, Says Needham
- Investors Business Daily
-
Piper's 17 biopharma surprises for 17
- Seeking Alpha
-
Valeant Is The Answer To Gilead's Problems
- Seeking Alpha
-
3 Stocks That Could Get Pounded by Tax Loss Selling
- InvestorPlace.com
-
Allergan: You Can't Be Negative On This One
- Seeking Alpha
-
Apple, General Electric, Microsoft Lead Field In Stock Buybacks
- Investors Business Daily
-
- Seeking Alpha
-
Allergan to Buy LifeCell For $2.9 Billion
- Investopedia.com
-
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
- Seeking Alpha
- Loading more headlines...
Press Releases on AGN
-
Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference
- PR Newswire - PRF
-
Acelity to Sell LifeCell Business Unit to Allergan
- BusinessWire - BZX
-
Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion
- PR Newswire - PRF
-
Fitch Affirms Allergan at 'BBB-'; Outlook Stable
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Reward | % | 15.27% | 15.29% |
| Student | % | 13.42% | 13.42% |
| Cash Back | % | 15.38% | 15.32% |
| Instant Approval | % | 17.86% | 18.04% |
| Business | % | 13.16% | 13.12% |
| Low Interest | % | 12.00% | 11.98% |
| Balance Transfer | % | 14.44% | 14.38% |
| Bad Credit | % | 22.86% | 22.56% |
| Airline | % | 15.15% | 15.08% |




